Plaque Psoriasis
The MD Magazine Plaque Psoriasis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Case Study Points to Potential New Treatment for Patients with Vitiligo
Patients with vitiligo have a choice of many treatment options, which run the gamut from applying make-up to depigmented areas, to light treatment, all the way up to surgery to move pigmented skin cells to affected areas. Yet, many patients elect not to treat the condition at all, despite the fact that the condition can be emotionally devastating and progressive.
Aerosol foam calcipotriol/betamethasone diproprionate (Enstilar/LEO Pharma) has been shown to successfully and rapidly relieve itchiness and improve itch-related sleep loss in patients suffering from psoriasis vulgaris (plaque psoriasis).
Results from a novel phase 3 study show treatment with adalimumab (Humira/AbbVie) produces favorable outcomes in young patients with plaque psoriasis.
Compared with controls, patients with psoriasis vulgaris do not have significant differences in general psychiatric symptoms and strategies for coping, but do have lower sleep quality, according to a study published online May 6 in the International Journal of Dermatology.
Interleukin-17, one of the T-helper 1 (Th17) subtypes had been reported to be a significant trigger for plaque psoriasis however the specific contribution of each cytokine group still remains questionable.
Although psoriatic arthritis (PsA) only targets those diagnosed with psoriasis, a genetic factor has been discovered that only pinpoints the former.
A 50-year-old forest ranger noted this rash, which he thinks has been present for several weeks. He noticed a similar rash on his dog. It is itchy, with a raised red border and a clear center. It may have increased in size slightly over several weeks. He is otherwise asymptomatic. What is the next step in treating him?

Most Popular

$vacMongoViewPlus$ $vAR$